Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)
1.310
-0.030
(-2.24%)
Streaming Delayed Price
Updated: 12:23 PM EDT, Sep 15, 2025
Add to My Watchlist
Press Releases about Lineage Cell Therapeutics, Inc. Common Stock
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
September 02, 2025
Via Business Wire
![]() ![]() ![]() ![]()
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
February 11, 2025
Via Business Wire
![]() ![]() ![]()
Lineage Cell Therapeutics Issues Letter to Stockholders
January 06, 2025
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|